NCT01625871已完成3 期
Artemether/Lumefantrine in the Treatment of Plasmodium Vivax Malaria in Eastern Sudan
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 38
- 试验地点
- 1
- 主要终点
- The cure rate
研究概览
简要总结
The cure rate of artemether/lumefantrine in the treatment of vivax malaria.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 5 Years 至 80 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with vivax malaria
排除标准
- •severe malaria
- •pregnancy
研究组 & 干预措施
artemether-lumefantrine
Experimental
tablets (containing 20mg artemether and 120 mg lumefantrine) for three days
干预措施: tablets artemether/lumefantrine (Drug)
结局指标
主要结局
The cure rate
时间窗: 28 days
The proportion of the cure patients
次要结局
- Fever clearance time(28 days)
- Parasite clearance time(28 days)
研究者
Ishag Adam
Professor
University of Khartoum
研究点 (1)
Loading locations...
相似试验
已完成
不适用
TES of Artemether-lumefantrine for Pf in the Philippines in 2015Malaria,FalciparumMalaria RecrudescenceNCT05958693Research Institute for Tropical Medicine, Philippines82
Unknown
4 期
Efficacy and Safety of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine in CameroonMalariaNCT05340153University of Yaounde 1184
已完成
4 期
Efficacy of Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria.Plasmodium Falciparum MalariaNCT02089841Richard Mwaiswelo140
已完成
不适用
Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy (TRANSACT)Uncomplicated MalariaNCT00868465Radboud University Medical Center600
已完成
3 期
Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy 2 (TRANSACT2)MalariaNCT01939886London School of Hygiene and Tropical Medicine219